Literature DB >> 8415646

A genotype of hepatitis D virus that occurs in northern South America.

J L Casey1, T L Brown, E J Colan, F S Wignall, J L Gerin.   

Abstract

Hepatitis D virus (HDV) is the cause of an unusually severe form of liver disease with distinct histologic features (morula cell) that occurs throughout northern South America and certain other areas of the world. Clinical studies of HDV disease worldwide indicate that there is, in fact, a wide variation in pathogenesis, and the reasons for these differences are presently unknown. One possible explanation is that factors associated with the viral genotype are determinants of HDV pathogenesis. In this study, nucleic acid sequences were determined for three different northern South American HDV isolates which were obtained from individuals with severe disease or a family history of severe disease, in areas that are hyperendemic for this disease pattern. The sequences of these three isolates are very similar to one another but only distantly related to other published HDV sequences. Comparison of the sequence of a semiconserved region from a total of 14 isolates indicates that there are at least three HDV genotypes. Most published HDV sequences, including those from North America, Europe, the Middle East, the South Pacific, and Asia, belong to a single genotype which may have some geographically based subtypes. A single Japanese isolate is the sole representative of a second HDV genotype. The South American sequences reported here constitute a third genotype. The association of a particular genotype with the severe form of type D hepatitis that occurs in northern South America supports the hypothesis that HDV genetic factors are important determinants in the pathogenesis of type D hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415646      PMCID: PMC47492          DOI: 10.1073/pnas.90.19.9016

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  trans-dominant inhibition of human hepatitis delta virus genome replication.

Authors:  J S Glenn; J M White
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Complete nucleotide sequence of hepatitis delta virus RNA in Japan.

Authors:  F Imazeki; M Omata; M Ohto
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

4.  The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus.

Authors:  F L Chang; P J Chen; S J Tu; C J Wang; D S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus.

Authors:  M Y Kuo; L Sharmeen; G Dinter-Gottlieb; J Taylor
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Hepatitis delta virus infection and Labrea hepatitis.

Authors:  E Strauss
Journal:  JAMA       Date:  1988-06-24       Impact factor: 56.272

7.  Sequence conservation and divergence of hepatitis delta virus RNA.

Authors:  Y C Chao; M F Chang; I Gust; M M Lai
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

8.  Evolution of hepatitis delta virus RNA during chronic infection.

Authors:  C M Lee; F Y Bih; Y C Chao; S Govindarajan; M M Lai
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

9.  An epidemic of hepatitis D in the foothills of the Himalayas in south Kashmir.

Authors:  M S Khuroo; S A Zargar; R Mahajan; G Javid; R Lal
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

10.  The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece.

Authors:  S J Hadziyannis; C Papaioannou; A Alexopoulou
Journal:  Prog Clin Biol Res       Date:  1991
View more
  67 in total

1.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.

Authors:  Brendan O'Malley; David W Lazinski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Authors:  Jinhong Chang; Severin O Gudima; John M Taylor
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

5.  The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2009-04-21       Impact factor: 4.942

6.  Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon.

Authors:  S Ramia; M El-Zaatari; A I Sharara; F Ramlawi; B Farhat
Journal:  Epidemiol Infect       Date:  2006-12-19       Impact factor: 2.451

7.  Core-associated non-duplex sequences distinguishing the genomic and antigenomic self-cleaving RNAs of hepatitis delta virus.

Authors:  T S Wadkins; M D Been
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

8.  Identification and characterization of a hepatitis delta virus RNA transcriptional promoter.

Authors:  M R Beard; T B MacNaughton; E J Gowans
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.